Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer - Concepedia

Concepedia

Publication | Open Access

Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer

DOI Full Paper Access

70

Citations

56

References

2022

Year

Tizita Zeleke, Qingfei Pan, Codruța Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan, Mariano J. Alvarez, Erin Honan, Min Yang, Pei Ling Chia,

Breast OncologyOncologyMedicinePharmacologyBreast CancerHdac6 ActivitySystems BiologyCancer BiologyRadiation OncologyTumor MicroenvironmentCancer ResearchHdac6 Inhibitor Ricolinostat

References

	Year	Citations

Page 1

Page 1